305 related articles for article (PubMed ID: 36556464)
1. Improving Osteosarcoma Treatment: Comparative Oncology in Action.
Tarone L; Mareschi K; Tirtei E; Giacobino D; Camerino M; Buracco P; Morello E; Cavallo F; Riccardo F
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556464
[TBL] [Abstract][Full Text] [Related]
2. Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma.
Riccardo F; Tarone L; Iussich S; Giacobino D; Arigoni M; Sammartano F; Morello E; Martano M; Gattino F; Maria R; Ferrone S; Buracco P; Cavallo F
Ther Adv Med Oncol; 2019; 11():1758835919855491. PubMed ID: 31217827
[TBL] [Abstract][Full Text] [Related]
3. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
4. A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma.
Tarone L; Giacobino D; Camerino M; Maniscalco L; Iussich S; Parisi L; Giovannini G; Dentini A; Bolli E; Quaglino E; Merighi IF; Morello E; Buracco P; Riccardo F; Cavallo F
Mol Ther; 2023 Aug; 31(8):2342-2359. PubMed ID: 37312451
[TBL] [Abstract][Full Text] [Related]
5. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
6. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.
Fan TM; Roberts RD; Lizardo MM
Front Oncol; 2020; 10():13. PubMed ID: 32082995
[TBL] [Abstract][Full Text] [Related]
7. Recent and current clinical trials in canine appendicular osteosarcoma.
Poon AC; Matsuyama A; Mutsaers AJ
Can Vet J; 2020 Mar; 61(3):301-308. PubMed ID: 32165755
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.
Varshney J; Scott MC; Largaespada DA; Subramanian S
Vet Sci; 2016 Jan; 3(1):. PubMed ID: 29056713
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.
Baldanza VE; Rogic A; Yan W; Levine CB; Levine RA; Miller AD; McCleary-Wheeler AL
PLoS One; 2020; 15(4):e0231762. PubMed ID: 32348319
[TBL] [Abstract][Full Text] [Related]
10. Murine and canine models of appendicular osteosarcoma.
Fan TM
Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.1. PubMed ID: 21948160
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic action of Brazilian propolis in vitro on canine osteosarcoma cells.
Cinegaglia NC; Bersano PR; Búfalo MC; Sforcin JM
Phytother Res; 2013 Sep; 27(9):1277-81. PubMed ID: 23074147
[TBL] [Abstract][Full Text] [Related]
12. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.
Alegre F; Ormonde AR; Snider KM; Woolard K; Yu AM; Wittenburg LA
PLoS One; 2018; 13(12):e0209941. PubMed ID: 30596759
[TBL] [Abstract][Full Text] [Related]
13. Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.
Wright T; Brisson BA; Wood GA; Oblak M; Mutsaers AJ; Sabine V; Skowronski K; Belanger C; Tiessen A; Bienzle D
Cytometry A; 2019 Sep; 95(9):997-1007. PubMed ID: 31282052
[TBL] [Abstract][Full Text] [Related]
14. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review.
Valdivia G; Alonso-Diez Á; Pérez-Alenza D; Peña L
Front Vet Sci; 2021; 8():623800. PubMed ID: 33681329
[TBL] [Abstract][Full Text] [Related]
15. Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.
Barutello G; Rolih V; Arigoni M; Tarone L; Conti L; Quaglino E; Buracco P; Cavallo F; Riccardo F
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534457
[TBL] [Abstract][Full Text] [Related]
16. Effect of surgical site infection on survival after limb amputation in the curative-intent treatment of canine appendicular osteosarcoma: a Veterinary Society of Surgical Oncology retrospective study.
Hans EC; Pinard C; van Nimwegen SA; Kirpensteijn J; Singh A; MacEachern S; Naber S; Dudley RM
Vet Surg; 2018 Nov; 47(8):E88-E96. PubMed ID: 30303552
[TBL] [Abstract][Full Text] [Related]
17. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.
Simpson S; Dunning MD; de Brot S; Grau-Roma L; Mongan NP; Rutland CS
Acta Vet Scand; 2017 Oct; 59(1):71. PubMed ID: 29065898
[TBL] [Abstract][Full Text] [Related]
18. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
19. Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development.
Regan D; Garcia K; Thamm D
ILAR J; 2018 Dec; 59(1):99-110. PubMed ID: 30668709
[TBL] [Abstract][Full Text] [Related]
20. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
